ArticlePharmaceutics2023

Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus.

Burcu Özkan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.